Advanced Bioengineering
Discover the world of advanced bioengineering with ATUM – your life science partner!
Integrated solutions accelerate timelines from discovery to manufacturing, preclinical research to IND applications.
DNA. Antibodies. Cell lines.
Discovery with manufacturing in mind!
Struggling with unpredictable cell line productivity and CQAs in biologics manufacturing? Discover how ATUM's discoCHO platform revolutionizes the process by seamlessly integrating discovery hits into our CHO-K1-based stable miCHO-GS platform—derisking your path to manufacturing success. Click here to learn more.
POWERED BY MACHINE LEARNING
From Virtual Sequence to Master Cell Bank
ATUM is a fully integrated biotechnology leader since 2003 providing the highest quality Gene Design & Synthesis, Protein Production, Protein Engineering, and Cell Line Development.
With our state-of-the-art machine learning platform, we take you from virtual sequence to Master Cell Bank with a click of the button.
With our state-of-the-art machine learning platform, we take you from virtual sequence to Master Cell Bank with a click of the button.
![VID_9548](/wp-content/uploads/2024/03/VID_9548.jpg)
![VID_9561](/wp-content/uploads/2024/03/VID_9561.jpg)
![VID_9580](/wp-content/uploads/2024/03/VID_9580.jpg)
![VID_9559](/wp-content/uploads/2024/03/VID_9559.jpg)
![TaylorMurphey](/wp-content/uploads/2024/01/TaylorMurphey-e1711420122802.jpg)
![alexa](/wp-content/uploads/2024/08/alexa.jpeg)
![mario](/wp-content/uploads/2024/08/mario.jpeg)
![alain](/wp-content/uploads/2024/08/alain.jpeg)
We think of projects more as a collaboration than services. We combine your expertise with our expertise so that together we succeed. Whether you are selecting the best vector and codon optimization for a gene to express in your own lab, or you want us to take you from hybridoma sequence to high producing cell line, our team is ready to help.
ATUM In The World
![](/wp-content/uploads/2024/08/ScreenShot52.png)
July 9, 2024
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
![](/wp-content/uploads/2024/08/ScreenShot9-1.png)
February 22, 2024
Mitigating the aggregation challenge in immunocytokine production: Strategies during cell line development and purification optimization
![](/wp-content/uploads/2024/08/ScreenShot9.png)
January 4, 2024
Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters
![](/wp-content/uploads/2024/02/Mercury_News_Logo.png)
December 1, 2021
Will we be protected from COVID-19’s omicron variant? Bay Area researchers sprint to find out